The Frequency of Thyroid Diseases in Women With Breast Cancer
Sponsor
Uşak University (Other)
Overall Status
Completed
CT.gov ID
NCT04406779
Collaborator
(none)
160
13
Study Details
Study Description
Brief Summary
Breast cancer and thyroid disorders are important health challenges commonly encountered in women. The relationship between both conditions still remains unknown. In this study, the frequency of thyroid diseases was investigated in breast cancer patients
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
160 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Frequency of Thyroid Diseases in Women With Breast Cancer
Actual Study Start Date
:
Mar 1, 2016
Actual Primary Completion Date
:
Mar 31, 2017
Actual Study Completion Date
:
Mar 31, 2017
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patients with breast cancer Patients with breast cancer |
Device: thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
|
| Control Healthy patients without breast cancer |
Device: thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
|
Outcome Measures
Primary Outcome Measures
- to investigate the frequency of thyroid diseases in breast cancer patients. [1 year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
- women, the age between 18-65 years who were diagnosed with breast cancer, but not underwent surgery, radiotherapy or chemothreapy were included into the study
Exclusion Criteria:
- Those with pregnancy, known liver and renal failure, the history of any malignancy other than breast cancer, undergoing a surgical operation due to breast cancer, also those receiving chemotherapy/radiotherapy for the same reason or undergoing partial or complete thyroid surgery or a surgical operation within the past 6 months, and also the patients taking oral anti-diabetic medication, insulin, steroids, thiazide, anti-psychotics and immuno-suppressive medicines affecting the levels of blood glucose, insulin and IR, smokers and those consuming alcohol were excluded
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Uşak University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Cevdet Duran,
M.D.,
Uşak University
ClinicalTrials.gov Identifier:
NCT04406779
Other Study ID Numbers:
- UsakU-Cevdet1
First Posted:
May 28, 2020
Last Update Posted:
May 28, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: